Letter: Sars-CoV2
Vaccinations of the young Dear Editor, Mark Hilliard’s Covid Q+A in the Irish Times (27/7/21) contains a very interesting number, i.e. the risk to the
Stay updated with breaking news from Use Authorisations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaccinations of the young Dear Editor, Mark Hilliard’s Covid Q+A in the Irish Times (27/7/21) contains a very interesting number, i.e. the risk to the
Expect WHO Nod To Covaxin In July-Sept, Says Bharat Biotech Amid Travel Fears Indiatimes 4 days ago © Provided by Indiatimes Vaccine developer Bharat Biotech said it expects approval for its Covid-19 vaccine Covaxin from the World Health Organisation (WHO) for emergency use listing (EUL) by July-September. Approvals in process in over 60 nations The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others. With this, Covaxin became the second India-made vaccine to apply at the global health agency for author...
Phase 3 interim results of Covaxin released April 21, 2021 Clinical efficacy at 78%; 100% efficacy against severe Covid-19 disease: Bharat Biotech Bharat Biotech has announced Phase 3 interim analysis results of Covaxin, following a second interim analysis based on 87 symptomatic cases of Covid-19. Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a point estimate of vaccine efficacy of 78 per centagainst mild, moderate, and severe Covid-19 disease. The efficacy against severe Covid-19 disease was 100 per cent, with an impact on reduction in hospitalisations...